Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study With Single/Multiple Dose Administered to Explore the Safety/Tolerability and Pharmacokinetics of GFH018 in the Treatment of Patients With Advanced Solid Tumors

NCT05051241 is registered in ClinicalTrials.gov with Zhejiang Genfleet Therapeutics Co., Ltd. as lead sponsor.

NCT NCT05051241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05051241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study With Single/Multiple Dose Administered to Explore the Safety/Tolerability and Pharmacokinetics of GFH018 in the Treatment of Patients With Advanced Solid Tumors
Lead sponsor
Zhejiang Genfleet Therapeutics Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
August 30, 2019
Completion date
August 11, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor